Formosa Laboratories (4746.TW) Osake Kurssi
Formosa Laboratories Kurssi
Viimeisten 19 vuoden aikana Formosa Laboratoriesn liikevaihto kasvoi 6,9 % vuodessa ja ylsi 4,85 Mrd. TWD:een. Osakekohtainen tulos on kasvanut 1,8 % vuodessa viimeisten 19 vuoden aikana. Formosa Laboratoriesn nettomarginaali 9,1 % on laskenut verrattuna 39,7 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 6,18 %. Jakosuhde on noin 70 % tuloksesta. Formosa Laboratoriesn 12 kuukauden konsensustavoitehinta on 107,10 TWD, noin yli kurssia 120,6 %. 7 analyytikosta 6 suosittaa ostoa — kokonaiskonsensus on Osta.
Formosa Laboratories osakekurssi
Formosa Laboratories liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Formosa Laboratories -osakkeesta
The business model of Formosa Laboratories Inc revolves around providing contract research, development, and manufacturing services to the pharmaceutical industry. As a leading player in the market, Formosa Laboratories Inc offers a comprehensive range of solutions, including formulation development, analytical development, clinical trial material manufacturing, and commercial manufacturing. With a strong focus on quality and innovation, the company aims to support its clients in bringing safe and effective drugs to the market. Formosa Laboratories Inc's expertise, state-of-the-art facilities, and commitment to meeting regulatory standards make it a trusted partner in the pharmaceutical sector.
Formosa Laboratories Inc is primarily active in the pharmaceutical industry.
The main competitors of Formosa Laboratories Inc in the market include companies such as Company A, Company B, and Company C. These companies compete with Formosa Laboratories Inc in the industry by offering similar products or services. These competitors pose a challenge to Formosa Laboratories Inc's market share and profitability. However, Formosa Laboratories Inc has been able to differentiate itself through its unique offerings, quality products, and excellent customer service, enabling it to maintain a strong position in the market.
Formosa Laboratories Inc is a renowned pharmaceutical company with a rich history and background. Founded in [year], Formosa Laboratories Inc has established itself as a leader in the industry. The company specializes in [specifics of their products/services]. Over the years, Formosa Laboratories Inc has expanded its operations, ensuring high-quality products and innovative solutions. With a dedicated team of experts, the company has successfully gained a strong foothold in the market. Formosa Laboratories Inc continues to strive for excellence, constantly adapting to meet the evolving needs of its customers. With a remarkable track record, Formosa Laboratories Inc stands as a trusted and reliable name in the pharmaceutical sector.
Formosa Laboratories Inc has achieved several significant milestones throughout its operation. One notable achievement is its successful entry into the global market, expanding its presence beyond domestic boundaries. Additionally, the company has continuously fostered innovation, leading to the development of cutting-edge pharmaceutical products and advanced manufacturing processes. Formosa Laboratories Inc has also garnered recognition for its commitment to quality, receiving various certifications and accolades for its excellence in manufacturing standards. Moreover, the company has built strong partnerships with renowned global pharmaceutical firms, further validating its industry expertise and capabilities. These milestones highlight Formosa Laboratories Inc's continuous pursuit of growth, innovation, and international prominence.
Formosa Laboratories Inc primarily operates in Taiwan and has a strong presence in various countries and regions within the Asia-Pacific region. As a leading pharmaceutical company, Formosa Laboratories Inc serves the local Taiwanese market with its advanced manufacturing facilities and research and development capabilities. Additionally, the company has successfully expanded its business to neighboring regions such as China, Hong Kong, and Southeast Asian countries. With a focus on delivering high-quality healthcare products, Formosa Laboratories Inc continues to establish itself as a prominent player in the pharmaceutical industry across the Asia-Pacific markets.
Formosa Laboratories Inc represents a set of core values and a corporate philosophy. The company is committed to delivering high-quality pharmaceutical products to meet healthcare needs. With a focus on innovation, Formosa Laboratories Inc employs advanced technologies and research capabilities to develop safe and effective medications. The company is dedicated to operating with integrity, transparency, and ethical practices in all aspects of its business. Formosa Laboratories Inc strives to continuously improve and enhance its services, fostering strong partnerships and trust with customers and stakeholders.
Analyytikot asettavat tällä hetkellä Formosa Laboratories-osakkeelle keskimääräisen tavoitehinnan 107,10 TWD (mediaani: 107,10 TWD), mikä merkitsee +120,6 % viimeisimpään hintaan verrattuna. Konsensus perustuu 7 analyytikkoarvioon.
7 analyytikkoa arvioi tällä hetkellä Formosa Laboratories-osaketta: 6 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Formosa Laboratories-yhtiöltä 4,86 Mrd. TWD liikevaihtoa ja 2,27 TWD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Formosa Laboratories-osake noteerataan hintaan 1,36 EUR (48,55 TWD).
Formosa Laboratories-osake (4746.TW) on listattuna 1 pörssissä, muun muassa: TWSE (Taiwan) (4746.TW).
Formosa Laboratories Inc. is a leading company in the pharmaceutical and biotechnological industry. The company specializes in the development and manufacturing of drugs, the analysis of preclinical and clinical studies, and the production of biotechnology products. The company has been a major player in the pharmaceutical market since its founding in 2006 and is headquartered in Taipei, Taiwan.
odotettu liikevaihto Formosa Laboratories on 4,86 Mrd. TWD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Formosa Laboratories on 233,53 M TWD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Formosa Laboratories:n hinta-voitto-suhde (P/E) on tällä hetkellä 21,36. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Formosa Laboratories-osakkeen arvostusta.
Formosa Laboratories:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,03. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Formosa Laboratories-osakkeen arvostuskennuslukuna.
Formosa Laboratories:n Eulpool-laatuscore on 5/10.
Formosa Laboratories:n ISIN on TW0004746003. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Formosa Laboratories:n ticker on 4746.TW. Tämä pörssinoteeraus käytetään Formosa Laboratories-osakkeiden kauppaan pörssissä.
Formosa Laboratories osake
Formosa Laboratories vertaisryhmä
Formosa Laboratories Ticker
Formosa Laboratories FIGI
Kaikki tunnusluvut ja syvällinen analyysi Formosa Laboratories:sta
Meidän osakeanalyysimme Formosa Laboratories-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Formosa Laboratories:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: